entertainment -WSS

entertainment

author：fashion 2025-09-30 00:45:21 - browse：98927

Stock photograph of a tall pile of journals or magazines on a black background — Adobe

There was a time when an allegation of data mishandling, scientific misconduct, or just a technical error felt like a crisis to Barrett Rollins, an oncologist and research integrity officer at Dana-Farber Cancer Institute. Now, it’s a Tuesday.

The renowned cancer treatment and research center is in the midst of a lengthy review of possible discrepancies involving around 60 papers co-authored by four of its top researchers over a period of over 15 years, including CEO Laurie Glimcher and COO William Hahn. And it’s hardly alone. Over the past decade, the number of research misconduct allegations reported to the National Institutes of Health has more than doubled, climbing from 74 in 2013 to 169 in 2022. And scientific sleuths are finding plenty of other problems that don’t always qualify as outright misconduct.

One analysis of PubPeer, a website where users can anonymously comment on scientific papers, found that out of a sample of nearly 25,000 comments, 62% were about alleged data manipulation. Nearly 80% of these comments were on health or life sciences studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Republican states more likely to report Covid vaccine side effects

WSS

Scientific mystery highlights the blind spots in genomics databases

Investment in vaccine development is lagging, report finds

New clues to why women have higher risk of autoimmune disorders

Pancreatic cancer early detection could be helped by AI

Humana’s losses in Medicare Advantage tank its stock

Covid silver lining: Unprecedented look at human immune system

leisure time

entertainment

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Trial using CRISPR to edit HIV out of cells disappoints

Hepatitis C has a cure — but many Americans still lack access to it

First Opinion on colorectal cancer screening: letter and response

Medical records are filled with copy

Medicare drug price negotiation legal challenge met with skepticism

Activists slam private health insurers over coverage restrictions

Zyn nicotine pouches become unlikely player in latest culture war

Dobbs anniversary: the lost opportunity of abortion as health care

Why Medicare shouldn’t cover every FDA

hotspot

First Opinion on colorectal cancer screening: letter and response

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Medicare Advantage 2025 payments will dip, Biden administration says

Health Care Service Corp to buy Cigna Medicare Advantage plans

Researchers test human milk's ability to repair gut microbiome

Bird flu reported in person exposed to presumably infected cattle

explore

hotspot

focus

hotspot